Clinical Trial Update: MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC [NA]

View source ↗

Summary

The MultiSCRIPT-Cycle 1 study is a pragmatic platform trial embedded within the SMSC aimed at personalized medicine approaches for Relapsing-Remitting Multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Multiple Sclerosis, Relapsing-Remitting | NA | Status: ACTIVE_NOT_RECRUITING